RxDoctor Payments Data

Christy Jones, APRN

Family · Hays, KSNPI 1598487670

Payments from drug & device makers

$1,222in general payments, 2019–2025

Across 50 payments — averaging $24.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$452
  • Amgen$175
  • Novartis$167
  • AstraZeneca$91
  • E.r. Squibb & Sons, L.L.C.$60
  • Pfizer$51
  • plus $227 from 10 others

What the payments were for

  • Travel & lodging$18815%
  • Food & beverage$1,03485%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,222 in reported general payments places this provider in the 75th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$37,346
Medicare patients
390
Services billed
558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban156$106,437
BrilintaTicagrelor57$26,840
FarxigaDapagliflozin Propanediol17$12,730
EntrestoSacubitril/Valsartan17$11,417
Repatha SureclickEvolocumab12$9,821
XareltoRivaroxaban13$6,831
Metoprolol Succinate181$1,773
Potassium Chloride84$1,330
Atorvastatin Calcium189$1,293
Bumetanide39$1,227
Rosuvastatin Calcium100$806
Losartan Potassium110$732
Ezetimibe34$575
Carvedilol100$567
Flecainide Acetate29$554

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$51$106,437156 claims
AstraZenecaBrilinta, Farxiga$91$39,57074 claims
NovartisEntresto$167$11,41717 claims
Johnson & JohnsonXarelto$16$6,83113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,579 family providers in Kansas.

Other family in Hays

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →